• info@microlabs.in
  • +91-80-2237 0451-57 / +91-80-2237 0463
  • ADR
  • Blogs
  • Careers
  • Contact
Logo
  • About
    • About Micro Labs
    • Vision & Values
    • Awards & Milestones
  • Business Segment
    • API
    • Formulations
    • Therapies
  • Infrastructure
    • Manufacturing Plants
    • R&D
    • IIC
  • Global Presence
  • Giving Back
    • Social Impact
    • CSR
  • Media
    • Blogs
    • News & Press
    • Announcements

News & Press

  • Home
  • News & Press
Thumb

Brand Dolo being expanded in OTC space via Micro Wellness

  • Trending News

As lifestyle diseases continue to rise, Micro Labs, the maker of Dolo, is expanding its focus on its newly structured wellness segment. The company is capitalising on the popularity of the Dolo brand by launching an over-the-counter segment under the same name such as Dolo pain relief spray, Dolosils Cough Lozenges or Dolo Fevometer. “From lozenges, gel sprays, thermometers, antacids, and nicotine gums, we are significantly expanding our wellness product offerings. This strategic move aligns with the growing demand for lifestyle solutions, complementing our existing focus on chronic disease therapies," Diya Surana, head, strategy, digital transformation and OTC wellness, Micro Labs told News18 in her first exclusive interaction.

Thumb

Micro Labs has acquired Swiss Pharma Nigeria Limited (Swipha)

  • Trending News

As part of efforts to expand its footprints across African Continent, Micro Labs Limited (Micro Labs), India has acquired Swiss Pharma Nigeria Limited (Swipha), a leading pharmaceutical company in Nigeria.

Thumb

Introducing Trisopt: The World's First Triple Drug Combo for Glaucoma

  • The Print

Micro Labs Ltd introduces Trisopt: World’s first triple drug fixed-dose combination for Glaucoma Management.Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim.

Thumb

Micro Labs Ltd, disrupting the Indian pharmaceutical industry since 1973

  • The CEO Magazine

Today, Dolo-650 is the 6th largest brand (as per AWACS) in the Indian Pharmaceutical Market became the number one prescribed brand of paracetamol solid oral doses in India.

Thumb

The Brand Story Media recognized Dolo-650 as India’s leading brand

  • Hindustan Times

Dolo-650 gets recognized as India’s Leading Brand at the Indian Brand and Leadership Conclave 2022 organized by The Brand Story.

Thumb

How Micro Labs struck Gold with Dolo-650

  • Forbes India

The company has sold 350 crore tablets since the Covid-19 outbreak in 2020, and earned revenues of Rs 400 crore in a year

Thumb

How Dolo 650 became the Go to Drug during the pandemic

  • The India Express

Easy availability and being the doctors’ preferred prescription during the second wave.

Quick Links

  • Home
  • Global Presence
  • Careers
  • Contact Us

About

  • About Micro Labs
  • Vision & Values
  • Awards & Milestones

Infrastructure

  • Manufacturing Plants
  • R&D
  • IIC

Business

  • API
  • Formulations
  • Therapies

Media

  • Social Impact
  • Blogs
  • News & Press
  • Announcements

Policies

  • Privacy Policy
  • NRC
  • Returns Report
  • Code of Conduct
  • Vigil Mechanism
  • CSR

Victory over Diabetes | Iamonsaltsatyagraha_microlabs

Victory over Diabetes
Iamonsaltsatyagraha_microlabs

Copyright @MICRO LABS LTD. All rights reserved.

  • Developed By @BubbleNetwork